Alpha Pharma is thrilled to announce the signature of the Memorandum of Understanding with Biotest AG for the private label of plasma derivatives products for the KSA market to serve patients suffering from various immune, blood and other illnesses.

‘4th Oct 2022 – Signing Ceremony of the Memorandum of Understanding between Alpha Pharma and Biotest AG
at Cigalah Group Headquarters in Jeddah, KSA’

“I am proud to see Alpha Pharma establishing strategic partnership with Biotest AG and creating the unique opportunity of being the first Saudi producer of plasma- based innovative therapies for patients in Saudi and other countries across the GCC region.” Shaikh Yaser Al Naghi, Chairman of Alpha Pharma and Group CEO of Cigalah Healthcare.

Read the full press release here: (